Your browser doesn't support javascript.
loading
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.
Klemen, Nicholas D; Wang, Melinda; Feingold, Paul L; Cooper, Kirsten; Pavri, Sabrina N; Han, Dale; Detterbeck, Frank C; Boffa, Daniel J; Khan, Sajid A; Olino, Kelly; Clune, James; Ariyan, Stephan; Salem, Ronald R; Weiss, Sarah A; Kluger, Harriet M; Sznol, Mario; Cha, Charles.
Afiliação
  • Klemen ND; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Wang M; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Feingold PL; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Cooper K; Department of Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Pavri SN; Orlando Health Aesthetic and Reconstructive Surgery Institute, Orlando, FL, USA.
  • Han D; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA.
  • Detterbeck FC; Section of Thoracic Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Boffa DJ; Section of Thoracic Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Khan SA; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Olino K; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Clune J; Section of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Ariyan S; Section of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Salem RR; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA.
  • Weiss SA; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Kluger HM; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Sznol M; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Cha C; Section of Surgical Oncology, Yale School of Medicine, 20 Park Street, New Haven, CT, 06519, USA. charles.cha@yale.edu.
J Immunother Cancer ; 7(1): 196, 2019 07 24.
Article em En | MEDLINE | ID: mdl-31340861

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido